Omnicell End Period Cash Flow Over Time
| OMCL Stock | USD 45.96 0.27 0.59% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Omnicell Performance and Omnicell Correlation. Omnicell |
Is Health Care Technology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Omnicell. If investors know Omnicell will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Omnicell listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.558 | Earnings Share (0.39) | Revenue Per Share 23.218 | Quarterly Revenue Growth (0.05) | Return On Assets (0.01) |
The market value of Omnicell is measured differently than its book value, which is the value of Omnicell that is recorded on the company's balance sheet. Investors also form their own opinion of Omnicell's value that differs from its market value or its book value, called intrinsic value, which is Omnicell's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Omnicell's market value can be influenced by many factors that don't directly affect Omnicell's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Omnicell's value and its price as these two are different measures arrived at by different means. Investors typically determine if Omnicell is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Omnicell's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities End Period Cash Flow Analysis
Compare Omnicell and related stocks such as HealthStream, National Research Corp, and Nextgen Healthcare End Period Cash Flow Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| HSTM | 13.6 M | 76.9 M | 41.4 M | 59.5 M | 82 M | 82 M | 49.6 M | 84.8 M | 134.3 M | 131.5 M | 36.6 M | 46.9 M | 46 M | 40.3 M | 45.1 M |
| NRC | (2.4 M) | 8.1 M | 8.3 M | 22.1 M | 40 M | 42.1 M | 33 M | 34.7 M | 13 M | 13.5 M | 34.7 M | 54.4 M | 25 M | 6.7 M | 6.3 M |
| FORA | 494 | 494 | 494 | 494 | 494 | 494 | 494 | 494 | 494 | 494 | 665.5 K | 18.7 M | 3.3 M | 6 M | 6.3 M |
| DH | 8.6 M | 8.6 M | 8.6 M | 8.6 M | 8.6 M | 8.6 M | 8.6 M | 8.6 M | 8.6 M | 8.6 M | 24.8 M | 387.5 M | 146.9 M | 131 M | 153.7 M |
| EVH | 5.3 M | 5.3 M | 5.3 M | (80 M) | (80 M) | 145.7 M | 134.6 M | 295.4 M | 388.3 M | 128.5 M | 361.6 M | 354.9 M | 215.2 M | 223.5 M | 217.3 M |
| CMAX | 282 K | 282 K | 282 K | 282 K | 282 K | 282 K | 282 K | 282 K | 282 K | 4.4 M | 4.9 M | 47.9 M | 41.6 M | 65.5 M | 68.8 M |
| CERT | 12.2 M | 12.2 M | 12.2 M | 12.2 M | 12.2 M | 12.2 M | 12.2 M | 12.2 M | 12.2 M | 29.8 M | 273.3 M | 186.6 M | 239.7 M | 235 M | 179 M |
Omnicell and related stocks such as HealthStream, National Research Corp, and Nextgen Healthcare End Period Cash Flow description
My Equities
My Current Equities and Potential Positions
| Omnicell | OMCL |
Specialization | Health Care, Health Care Equipment & Services |
| Location | California; U.S.A |
| Exchange | NASDAQ Exchange |
USD 45.96
Check out Omnicell Performance and Omnicell Correlation. For more information on how to buy Omnicell Stock please use our How to buy in Omnicell Stock guide.You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Omnicell technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.